Serum concentrations of glycoprotein hormone oa subunit are raised in some patients with tumours (Franchimont et al., 1972; Dosogne-Guerin et al., 1978) and ectopic synthesis and secretion of a subunit has been demonstrated using various in vitro methods (Weintraub et al., 1973; Walker 1978) . Serum a subunit may be of value, therefore as a marker in patients with certain types of tumour. The serum concentration depends partly upon secretion from the pituitary which is linked to that of the intact glycoprotein hormones, as well as on possible ectopic secretion. Concentrations are increased in hypergonadotrophic states such as after the menopause (Kourides et al., 1977) and at the time of the preovulatory LH surge (Rosemberg & Bulat, 1979) Butt. In the LH assay, cross reaction of a subunit was 0.5%.
Serum concentrations of glycoprotein hormone oa subunit are raised in some patients with tumours (Franchimont et al., 1972; Dosogne-Guerin et al., 1978) and ectopic synthesis and secretion of a subunit has been demonstrated using various in vitro methods (Weintraub et al., 1973; Walker 1978) . Serum a subunit may be of value, therefore as a marker in patients with certain types of tumour. The serum concentration depends partly upon secretion from the pituitary which is linked to that of the intact glycoprotein hormones, as well as on possible ectopic secretion. Concentrations are increased in hypergonadotrophic states such as after the menopause (Kourides et al., 1977) and at the time of the preovulatory LH surge (Rosemberg & Bulat, 1979) Serum a subunit, LH, FSH, TSH and urea were measured in all samples. Serum a subunit was measured according to previously published methods from this laboratory. The upper limit of normal, defined as the 95% confidence limits for oc subunit, was <2.3ngnl-1 in men and pre-menopausal women and <9.5 ng ml-1 in post-menopausal women. In the a subunit assay, cross reaction of LH (NIBSC 68/40) was 12.5% (MacFarlane et al., 1979 (MacFarlane et al., ,1982 .
LH and FSH were measured using double antibody radioimmunoassays. The standards were NIBSC 68/40 for LH and NIBSC 78/549 for FSH. Antisera WRB F 87.2 (for LH) and WRB M 93.2 were kindly denoted by Professor W.R. Butt. In the LH assay, cross reaction of a subunit was 0.5%.
The TSH assay was also a double antibody radioimmunoassay using standard NIBSC 68/38 and antiserum kindly provided by the Tenovus Institute. Blood urea was measured using the Chemispek Instrument (Rank-Hilger, Margate).
Multiple regression analysis (MR) of oa on LH, FSH and age was determined by using the GLIM computer program package.
Using MR, serum LH was the single most important predictor of serum a subunit concentration, followed by age, in the control group of 132 healthy men, pre-menopausal women and post-menopausal women. Thirty eight patients with hypernephroma were studied, 23 men, age range 37-72 years, and 15 women, range 26-71 years. Of the women, 5 were pre-menopausal and 10 were post-menopausal. The mean (± s.d.) of pre-treatment serum ac subunit values in the men were 2.0 + 0.9 ng ml-1, range <0.5-3.8ngml 1, and in the women 2.8-2.1 ngml -1, range < 0.5-7.6 ng ml -1 Six of 23 men had serum a subunit values > 2.3 ng ml1, whilst only one woman had a raised value (3.8 ng ml 1 in a pre-menopausal woman). 1-1 (7-8) .
Following treatment mean LH concentration fell to 19.75+13.5IUVl' in the 6 men in whom serum a subunit had been > 2.3 ng ml-1. Serum ca subunit remained >2.3ngml1 in 4 of the men, but of the 3 in whom it had been higher than predicted pre-operatively, it remained higher than would have been predicted in 2 cases. In the 3 men in whom pre-operative serum ca subunit was within the predicted range, no increase above the predicted range was noted post-operatively. Serum ac subunit in the 3 men with initial values <2.3 ng ml-l but higher than predicted by MR remained higher than predicted in one patient.
Only one woman had a serum c i subunit value greater than predicted.
Our data show that serum ax subunit levels are significantly related to age and serum LH concentration. A highly significant correlation between serum cx and LH concentrations has been reported previously (Dosogne-Guerin et al., 1978) but the association with age is surprising. Increased serum ax subunit concentration may be found in primary hypothyroidism and renal failure, both of which are more common in older age groups. Measurement of serum TSH and urea concentrations, however, showed that the relationship of serum a subunit to age could not be explained on the basis of thyroid or renal disease.
Our data suggest that the apparently high serum oc subunit levels in some patients with tumours can, in a proportion of cases, be explained on the basis of raised serum LH levels. This finding may be due either to the increased secretion of a subunit in circumstances of increased LH secretion e.g. the pre-ovulatory LH surge in mid menstrual cycle (Rosemberg & Bulat, 1979) or to cross-reaction of LH in the a subunit assay (Papapetrou et al., 1985) . For the purposes of our calculations which relate serum a subunit concentration to LH levels, the mechanism of this relationship is immaterial, as the cross-reaction of LH and a subunit in each others assays is consistent. The finding of variation in serum gonadotrophin levels in patients with cancer is recognised (Chlebowski & Heler, 1982) but the mechanism is not known.
Multiple regression analysis allows us to distinguish elevated serum a subunit levels which are not due to changes in serum gonadotrophin concentration. A large study has suggested that serum a subunit values may be related to survival in some patients with melanoma (MacFarlane et al., 1979) . At present, however, routine use of a subunit in the screening and monitoring of patients with cancer would not seem to be useful in view of the problems addressed in this study. Because of the many types of tumours which have been associated with raised levels, however, a subunit measurement still remains potentially valuable. Further investigations, to determine whether serum x subunit will be of use in the management of patients with cancer will be facilitated by multiple regression analysis.
